Abstract
Collecting duct carcinoma configures as an exceptionally discerned renal cell carcinoma contributing to < 1% of renal neoplasms and depicts an aggressive clinical course. Tumefaction is confined to renal medulla and is posited to arise from principal cells of distal collecting ducts of Bellini. Collecting duct carcinoma is additionally designated as Bellini duct carcinoma or carcinoma of collecting ducts of Bellini. Therapeutic response to immunotherapy and chemotherapy is minimalistic. Prognostic outcomes are extremely adverse.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
